USANA Health Sciences (USNA) Downgraded by TheStreet

USANA Health Sciences (NYSE:USNA) was downgraded by TheStreet from a “b+” rating to a “c+” rating in a research report issued on Tuesday.

Other analysts have also issued research reports about the company. Pivotal Research upped their target price on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Wednesday, October 25th. BidaskClub raised USANA Health Sciences from a “sell” rating to a “hold” rating in a research note on Thursday, October 26th. Finally, Sidoti lowered USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th.

Shares of USANA Health Sciences (USNA) traded down $0.95 on Tuesday, reaching $74.10. The company’s stock had a trading volume of 8,874 shares, compared to its average volume of 84,730. The stock has a market capitalization of $1,697.47, a price-to-earnings ratio of 29.31 and a beta of 0.99. USANA Health Sciences has a 1-year low of $52.55 and a 1-year high of $79.00.

In other USANA Health Sciences news, Director Myron W. Wentz sold 5,304 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $66.01, for a total value of $350,117.04. Following the completion of the sale, the director now owns 12,011,418 shares of the company’s stock, valued at $792,873,702.18. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Global Ltd Gull sold 7,289 shares of the company’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $66.01, for a total value of $481,146.89. Following the completion of the sale, the insider now directly owns 11,996,192 shares of the company’s stock, valued at approximately $791,868,633.92. The disclosure for this sale can be found here. In the last ninety days, insiders sold 433,455 shares of company stock valued at $28,990,246. 53.20% of the stock is owned by insiders.

Several large investors have recently added to or reduced their stakes in USNA. US Bancorp DE boosted its stake in shares of USANA Health Sciences by 730.1% during the fourth quarter. US Bancorp DE now owns 2,374 shares of the company’s stock valued at $176,000 after purchasing an additional 2,088 shares during the period. Cubist Systematic Strategies LLC purchased a new stake in shares of USANA Health Sciences during the third quarter valued at approximately $189,000. Creative Planning purchased a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $219,000. Hikari Power Ltd purchased a new stake in shares of USANA Health Sciences during the fourth quarter valued at approximately $255,000. Finally, Trust Co. of Vermont boosted its stake in shares of USANA Health Sciences by 482.7% during the third quarter. Trust Co. of Vermont now owns 4,708 shares of the company’s stock valued at $272,000 after purchasing an additional 3,900 shares during the period. 44.26% of the stock is owned by hedge funds and other institutional investors.

WARNING: This piece of content was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://sportsperspectives.com/2018/02/08/usana-health-sciences-usna-downgraded-by-thestreet.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply